Chemoinformaics analysis of 5,9,10-TRIHYDROXY-2,2-DIMETHYLPYRANO[3,2-B]XANTHEN-6-ONE
| Molecular Weight | 326.304 | nRot | 0 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 8 |
| Exact Molecular Weight | 326.079 | nRing | 4 |
| Solubility: LogS | -3.522 | nHRing | 2 |
| Solubility: LogP | 3.57 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 44.2071 |
| nHD | 3 | BPOL | 18.3849 |
| QED | 0.525 |
| Synth | 3.64 |
| Natural Product Likeliness | 2.253 |
| NR-PPAR-gamma | 0.193 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.302 |
| MDCK | 0.0000199 |
| BBB | 0.977 |
| PPB | 0.814991 |
| VDSS | 1.61 |
| FU | 0.116396 |
| CYP1A2-inh | 0.306 |
| CYP1A2-sub | 0.306 |
| CYP2c19-inh | 0.178 |
| CYP2c19-sub | 0.784 |
| CYP2c9-inh | 0.081 |
| CYP2c9-sub | 0.836 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.79 |
| CYP3a4-inh | 0.279 |
| CYP3a4-sub | 0.307 |
| CL | 13.957 |
| T12 | 0.358 |
| hERG | 0.019 |
| Ames | 0.007 |
| ROA | 0.022 |
| SkinSen | 0.19 |
| Carcinogencity | 0.56 |
| EI | 0.714 |
| Respiratory | 0.851 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.649366 |